Home
Point of Care Diagnostics
27 October - 28 October 2008
Point of Care Diagnostics

Point of Care Diagnostic tests are projected to represent a market of $15 billion by 2010, and have experienced growth rates of around 10% per year. Their increasing implementation into clinical practice is changing the way that physicians operate, and new technological developments are opening up opportunities for those who commercialise POCT.

SAE Media Group’s conference on Point of Care Diagnostics will present a leading array of experts in this exciting field of healthcare technology. Presentations will address the following areas:

  • Market access, regulation and pricing and reimbursement for point of care diagnostics in the major markets of Europe, the US and the developing world.
  • Updates on the latest technology platforms – case studies from diagnostics providers will reveal the latest advances in diagnostic testing
  • The prospects for using PoC in the development of personalised medicine
  • How changing clinical practice is being affected by the implementation of point of care testing 

Our line-up of top speakers so far includes:

  • David Huckle, Chief Executive, Adam’s Business Associates
  • Neil Butler, CEO, Vicacta
  • Anil Modak, Associate Director, Medical Products Research and Development, Cambridge Isotope Laboratories
  • Gert Blankenstein, Head of Product Development, Boehringer Ingelheim microParts GmbH
  • Chris Price, Professor, University of Oxford
  • Mark Charny, Managing Director, Translucency *
  • Nanette Kerr, Head of Professional Services Development, Boots UK
  • Jon Cooper, Professor of Bioelectronics and Bioengineering, University of Glasgow
  • Mark O’Connell, Director, Probe Scientific
  • Representative of Frost and Sullivan
  • Gilbert Wieringa, Consultant Clinical Scientist, Greater Manchester PCT
  • Christina Rode-Schubert, Secretary General, Connectivity Industry Consortium Europe
  • Thomas Norgall, Fraunhofer-Institut für Integrierte Schaltunge.n Erlangen
  • Richard Taylor, Consultant Clinical Scientist, John Radcliffe Hospital
  • Steven Wong, Professor of Pathology & Scientific Director, Toxicology Department, Milwaukee County Examiners Office, Medical University of Wisonsin
  • Robert Jenkins, Corporate Business Development Manager, Biokit SA
  • Ciara O'Sullivan, Professor of Chemical Engineering, Universitat Rovira i Virgili

This event is targeted at those involved in developing, marketing and using point of care diagnostics, including the following job titles:

  • CSOs
  • CTOs
  • Directors/Heads/VPs of Diagnostic Research and Development
  • Directors/Heads/VPs of Business Development
  • Directors/Heads/VPs of Point of Care
  • Hospital CEOs, CIOs, CFOs
  • Physicians
  • Pharmacists
  • Pathologists
  • Clinical Scientists
  • Policy Makers

Previous years attendees have included representatives of the following companies:

  • Abbott Point of Care
  • Genzyme Diagnostics Ltd
  • Roche Diagnostics Ltd
  • ALK-Abello A/S
  • Biokit S.A
  • Nanogen
  • Irish Medicines Board
  • Diasys Diagnostic Systems
  • Institute of Biomedical Science
  • Securetec Detektions-Systeme AG
  • Health Protection Agency
  • Cytyc Development & Corporation
  • Orion Diagnostica Phadia AB
  • DiagnOx
  • Capio Diagnostics UK
  • Department of Health
  • Radiometer Medical APS
  • Connector
  • Meretek Diagnostics Inc
  • Tyco Healthcare Group L P
  • Nolato Medical
  • BioMerieux
  • Medifiq
  • Orion Corporation
  • Noiro
  • BIOSURFIT
  • Horiba ABX
  • Perlos Corporation
  • Laboratorios Leti S.L  
  • TriVirix
  • Johnson & Johnson/McNeil Consumer Healthcare

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

History & Current Status: Scene Setting

  • Past attempts at POCT and the lessons. Key Technical, User and Funding items.
  • Key external factors including who are the real users of Diagnostics.
  • clock

    9:30

    New Market Pull versus Old Market

  • The Market Drivers – User Segments, Suppliers, Regulations, Politics, Economics.
  • Why are there conflicts, their reality and how they will be resolved.
  • clock

    10:00

    POCT Technology Development

  • How new technologies and further developments are meeting User demands, changing skill levels of operators and the concerns of both Regulatory bodies and Analytical Biochemists.
  • Special attention will be given to the economic models that will support POCT.
  • clock

    10:40

    Morning Coffee

    clock

    11:10

    Applications of POCT – where tests mean action.

  • The role of POCT - where the immediate test result can allow action or no action that either saves lives and/or saves costs without harming overall Healthcare.
  • The areas where the total volume of testing would overwhelm the Central Laboratory or where the patient or test user demands cannot be met except by POCT.
  • clock

    11:40

    POCT Market Quantification & Projections for the Future

  • The current and developing market status.
  • The issues that are being addressed by Regulators, Reimbursement organisations and Healthcare funding groups.
  • Regional variations throughout the world with a reality check on the future markets. The timescales for future market development.
  • clock

    12:10

    Business Opportunities & Enhancing Technologies

  • Importance of development of the total Diagnostics market and the impact of other technologies that will enhance the use of POCT. Questions that will be considered include:
    - Are Central Laboratories the right way and what is their future role?
    - Are there other technologies that will change the use of Diagnostics that favour POCT?
    - What are the issues for Diagnostics suppliers?
    - What are the issues for POCT users?
    - What are the issues and driving role of Healthcare funders?
     
  • clock

    12:40

    Questions & Answers with interactive Review of the Workshop

    clock

    13:00

    Close of Workshop

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    David Huckle

    David Huckle, Chief Executive, Adams Business Associates

    clock

    9:10

    OPENING KEYNOTE – OVERVIEW OF THE POC SECTOR

    David Huckle

    David Huckle, Chief Executive, Adams Business Associates

  • Challenges in the development of point of care diagnostics
  • Business considerations
  • Solutions to problems
  • clock

    9:50

    GLOBAL MARKETING OF POCT

    Mark Charny

    Mark Charny, Managing Director, Translucency Ltd.

  • Details to be confirmed
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    POCT MARKET IN EUROPE

  • Changing market dynamics for POC tests in European market sector
  • Challenges to sellers and buyers
  • Pricing and Reimbursement
  • Acheiving market success
  • Arun A. K.

    Arun A. K., Senior Analyst & Team Leader - Clinical Diagnostics and Drug Discovery Technologies , Frost & Sullivan

    clock

    11:40

    THE POC MARKET IN GERMANY

    Gert Blankenstein

    Gert Blankenstein, Head of Business Microfluids, Boehringer Ingelheim Microparts Gmbh

  • Overview of German market
  • High levels of POC integration in the German healthcare system
  • The effect of implementation of DRGs into Germany
  • clock

    12:20

    Networking Lunch

    clock

    13:50

    IMPLEMENTATION AND SUPPORT OF POCT INTO NHS PRACTICE

    Richard Taylor

    Richard Taylor, Consultant Clinical Scientist, John Radcliffe Hospital

  • Implementation of POCT is a money saving strategy for NHS pathology
  • Bonuses of decentralisation of diagnosis for patient care
  • Bedside testing has useful applications throughout clinical practice
  • Prospects of increased personalised medicine will provide great savings
  • clock

    14:30

    IMPROVING OUTCOMES WITH POC TESTING

    Chris Price

    Chris Price, , Oxford University

    clock

    15:10

    Afternoon Tea

    clock

    15:40

    POINT OF CARE TESTING IN COMMUNITY PHARMACY: WHY BOTHER?

    Nanette Kerr

    Nanette Kerr, , Boots The Chemists

  • Background to testing in pharmacies
  • Credibility, professionalism and quality assurance
  • Patient accessibility, choice and the integrated care pathway
  • Supporting the government agenda
  • What next?
  • clock

    16:20

    POINT OF CARE DIAGNOSTICS IN MANCHESTER PHARMACIES: HYPE OR HOPE?

    Gilbert Wieringa

    Gilbert Wieringa, Healthcare Scientist Programme Lead, Department of Health

  • Outcomes from a 'High Street Testing' pilot
  • Delivering POCT in primary care
  • Commissioning new services
  • clock

    17:00

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chair's Opening Remarks

    Jon Cooper

    Jon Cooper, Professor of Bioelectronics and Bioengineering, University of Glasgow

    clock

    9:10

    TARGETING THE NEEDS IN POINT-OF-CARE IMMUNOASSAYS

    Neil Butler

    Neil Butler, Chief Executive, Vivacta

  • Rapid fully quantitative immunoassay platform for use at the Point-of-Care
  • Bringing the performance of the lab in terms of ultra-high sensitivity, dynamic range and precision
  • A fully homogenous assay: no red-cell separation, no wash steps
  • System designed for “CLIA Waived” simplicity in use
  • clock

    9:50

    STANDARDISATION: A STRATEGIC FACTOR OF POCT QUALITY CONTROL

  • Towards international standards for POCT – A brief history of the CIC
  • NCCLS POCT1-A standard – what is it about?
  • CIC EI cooperation partners IHE and CHA
  • Standard benefits for users & device vendors
  • Drivers for POCT connectivity: Guidelines & integration issues
  • New horizons
  • Christina Rode-Schubert

    Christina Rode-Schubert, Secretary General, Connectivity Industry Consortium

    Thomas Norgall

    Thomas Norgall, , Fraunhofer-Institut für Integrierte Schaltungen Erlangen

    clock

    10:30

    Morning Coffee

    clock

    11:00

    COMMUNICATION ENABLED MICROSYSTEMS FOR CLINICAL DIAGNOSTICS AND POPULATION SCREENING

    Ciara O'Sullivan

    Ciara O'Sullivan, ICREA Research Professor, Universitat Rovira I Virgili

  • Lab-on-a-chip
  • Biosensor arrays
  • Embedded communication
  • Microfluidics
  • Instrumentation
  • clock

    11:40

    POINT OF CARE – A WORLD OF POSSIBILITY DRIVEN BY TECHNOLOGY

    Robert Jenkins

    Robert Jenkins, Corporate Business Development Manager, Biokit S.A

  • The development of POC is becoming possible through the evolution of technology
  • Examples of how limits are being overcome by leveraging of new technology into products
  • The future - how POC will evolve in coming years
  • clock

    12:20

    Networking Lunch

    clock

    13:50

    POINT OF CARE DIAGNOSTIC TESTS FOR PERSONALISING ONCOLOGY DRUGS

    Anil Modak

    Anil Modak, Associate Director, Medical Products Research & Development, Cambridge Isotope Laboratories

  • Uracil-13C breath test for evaluating DPD deficiency prior to 5-Fluorouracil chemotherapy
  • Dextromethorphan-13C breath test for identifying poor metabolizers of CYP 2D6 enzyme prior to tamoxifen therapy
  • Pantoprazole-13C breath test for identifying CYP 2C19 enzyme polymorphism prior to cyclophosphamide medication
  • clock

    14:30

    MINITURISATION AND THE DEVELOPMENT OF LAB ON A CHIP TECHNOLOGY FOR POINT OF CARE DIAGNOSTICS

    Jon Cooper

    Jon Cooper, Professor of Bioelectronics and Bioengineering, University of Glasgow

  • Latest developments in nanotechnology for diagnostic testing
  • Microtechnology and microfluidics
  • Applications for Lab on a Chip
  • clock

    15:10

    Afternoon Tea

    clock

    15:40

    TECHNOLOGY PLATFORMS FOR IMPLEMENTING PERSONALISED MEDICINE

    Mark O'Connell

    Mark O'Connell, Director, Probe Scientific

  • Developments in body interfaces for PoC technologies
  • Beyond genotyping for personalised medicine?
  • clock

    16:20

    THE EMERGING USE OF POCT IN FORENSIC TOXICOLOGY AND PERSONALISED JUSTICE

    Steven Wong

    Steven Wong, Professor of Pathology & Scientific Director, Toxicology Department, Milwaukee County Examiners Office, Medical College of Wisconsin

  • Testing oral fluid for drug tests using point of care technologies
  • Rapid DNA extraction and molecular diagnostics enable pharmacogenomic analysis
  • These technologies enhance the emergence of ‘personalised justice’ in foresic/criminal settings
  • clock

    17:00

    Chair’s Closing Remarks and Close of Day One

    Workshops

    Crowne Plaza Hotel - St James

    Buckingham Gate 45/51
    London SW1E 6AF
    United Kingdom

    Crowne Plaza Hotel - St James

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.